Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01078428
Other study ID # Si 193/2009
Secondary ID 125/2552(EC4)
Status Completed
Phase Phase 4
First received February 27, 2010
Last updated January 24, 2014
Start date January 2010
Est. completion date June 2010

Study information

Verified date January 2014
Source Mahidol University
Contact n/a
Is FDA regulated No
Health authority Thailand: Ethical Committee
Study type Interventional

Clinical Trial Summary

Keloids and hypertrophic scars are a common subject of dermatologic consultations. Therapeutic management of such conditions remains challenging because of their high rate of recurrence and lack of curative treatment.


Description:

Silicone gel Sheeting (SGS) is one treatment modality that has proven effective for treatment of hypertrophic scar. One disadvantage of SGS is its application technique. To be effective, SGS must be applied on the scar for at least 12 hours daily. Topical silicone gel is a novel therapy that has shown promising result on scar prevention. However, the efficacy and safety of topical silicone gel for treatment of hypertrophic scar has not been confirmed.


Recruitment information / eligibility

Status Completed
Enrollment 38
Est. completion date June 2010
Est. primary completion date June 2010
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- subjects at least 18 years old

- subjects with hypertrophic abdominal scar

- Have not received treatment on the scar at least 1 month prior to the enrollment.

Exclusion Criteria:

- subject who has previous history of silicone allergy

- subject who smoke cigarette

- subject who was treated with x-rays irradiation in the past

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Intervention

Other:
Topical silicone gel
Topical silicone gel will be applied to the scar twice daily for a period of 8 weeks
Vaseline
Topical petrolatum gel will be applied to the scar twice daily for a period of 8 weeks

Locations

Country Name City State
Thailand Faculty of Medicine Siriraj Hospital Bangkoknoi Bangkok

Sponsors (1)

Lead Sponsor Collaborator
Mahidol University

Country where clinical trial is conducted

Thailand, 

References & Publications (4)

Chan KY, Lau CL, Adeeb SM, Somasundaram S, Nasir-Zahari M. A randomized, placebo-controlled, double-blind, prospective clinical trial of silicone gel in prevention of hypertrophic scar development in median sternotomy wound. Plast Reconstr Surg. 2005 Sep 15;116(4):1013-20; discussion 1021-2. — View Citation

Kloeters O, Tandara A, Mustoe TA. Hypertrophic scar model in the rabbit ear: a reproducible model for studying scar tissue behavior with new observations on silicone gel sheeting for scar reduction. Wound Repair Regen. 2007 Sep-Oct;15 Suppl 1:S40-5. doi: 10.1111/j.1524-475X.2007.00224.x. Erratum in: Wound Repair Regen. 2008 Jul-Aug;16(4):582. — View Citation

Li-Tsang CW, Lau JC, Choi J, Chan CC, Jianan L. A prospective randomized clinical trial to investigate the effect of silicone gel sheeting (Cica-Care) on post-traumatic hypertrophic scar among the Chinese population. Burns. 2006 Sep;32(6):678-83. Epub 2006 Jul 11. — View Citation

Murison M, James W. Preliminary evaluation of the efficacy of dermatix silicone gel in the reduction of scar elevation and pigmentation. J Plast Reconstr Aesthet Surg. 2006;59(4):437-9. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Scar thickness 1, 2 and 5 months after initiation of treatment Yes
Secondary Clinical assessment on overall scar appearance 1, 2 and 5 months after initiation of treatment Yes
See also
  Status Clinical Trial Phase
Completed NCT00993005 - CICATRIX in the Treatment of Hypertrophic Scars and Keloids Scars Phase 3
Withdrawn NCT02546076 - Comparison of Dual-mode ER:YAG Laser in Patients With Long Keloid/Hypertrophic Scars Phase 2
Withdrawn NCT01858038 - Gene Expression During Surgical Scar Remodeling by Fractional Photothermolysis N/A
Active, not recruiting NCT04389619 - Fractional Microneedling RF vs Intralesional Steroid With & Without Microneedling in Hypertrophic Scars N/A
Active, not recruiting NCT01113125 - Scars After Central Venous Catheters Phase 3
Active, not recruiting NCT00849004 - Prevention of Hypertrophic Scars or Keloids N/A
Completed NCT00142441 - Effect of Pulse Width on Scar Treatment Using a 595-nm Pulsed Dye Laser N/A
Withdrawn NCT02655211 - Laser Induced Bioengineered Remodeling of Thermally Injured Skin Trial N/A
Completed NCT02487212 - Treatment of Hypertrophic Scars Using Fractional Laser and Fractional Laser-assisted Topical Corticosteroid Delivery Phase 4
Active, not recruiting NCT04532840 - Effect of Cryotherpy on Hypertrophic Scar Phase 2/Phase 3
Recruiting NCT00548210 - Effectivity of Dermatix in Promoting Scar Maturation Phase 3